Quince Therapeutics, Inc. — SCHEDULE 13G/A Filings
4 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Quince Therapeutics, Inc. (QNCX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Quince Therapeutics, Inc. has filed 4 SCHEDULE 13G/A documents with the SEC since 2016. To view all SEC filings by Quince Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
POS AM
POS EX
POSASR
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001104659-25-112623 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001140361-25-039832 | Oct 30, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-042498 | Apr 30, 2025 | — |
| SCHEDULE 13G/A | — | 0001140361-25-004984 | Feb 18, 2025 | — |